Rights and permissions
About this article
Cite this article
US drug approval may be slowed by increasing demands on FDA. Inpharma Wkly. 1371, 4 (2003). https://doi.org/10.2165/00128413-200313710-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200313710-00008